A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Clinical trial NCT05263908 · COMPLETED

Trial details

NCT number: NCT05263908
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

SARS-CoV-2 Infection

Start date: 2022-03-31
Primary completion: 2023-07-10
Enrollment: 3346

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.